Review Article

Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy

Table 1

Literature summary of BM-MSC in the antifibrotic process.

ResearcherFibrogenic signal pathway involvedDelivery methodAnimal modelHeterogeneity

da Silva et al. [51]Not mentionedAbdominal vena cavaRat UUOSyngeneic
Asanuma et al. [52]Not mentionedRenal arteryRat UUOXenogeneic (from human)
Wu et al. [53]P38 and NF-κBi.v.Mouse BSA-induced proteinuria (CKD model)Murine
Ninichuk et al. [55]Not mentionedTail veinCOL4A3-deficient mouse (Alport disease model)Murine
Lang and Dai [56]TGF-β1/Smad3i.p.Rat STZ-induced diabetic nephropathySyngeneic
Matsui et al. [57]JAK-STAT3Renal arteryRat UUOXenogeneic (from human)
Song et al. [45]NF-κB and ERKTail veinADR-induced nephropathy mouse modelXenogeneic (from human)
Wang et al. [61]TGF-β1i.v.Mouse UUOXenogeneic (from human)

i.v.: intravenously; i.p.: intraperitoneally.